针对性风湿性关节炎治疗的生物仿真纳米平台:通过自我维持的积极反驱动的药物释放机制调节巨细胞
Huichao Xie1,2, Xiaoyu Huang1,3, Bao Li1,3
1College of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 22, 2025
概括
这项研究介绍了用于类风湿性关节炎 (RA) 治疗的新型纳米粒子. 该系统针对M1巨细胞,提供基因疗法和纳米酶以减少炎症和氧化应激,以有效管理RA.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 治疗策略侧重于减少关节炎症和改变巨细胞表型.
- 目前的方法面临着针对性交付和持续治疗效果的挑战.
研究的目的:
- 开发一种用于协同治疗RA的新型联合交付系统.
- 增强在炎症关节微环境中的向治疗和治疗疗效.
主要方法:
- 开发MACP siTNF-α纳米颗粒 (NP) 集成纳米酶和基因疗法.
- 用基聚合物和巨细胞膜进行序列修改,以实现向的输送.
- 使用一种自我维持的积极反机制,用于药物释放和ROS清理.
主要成果:
- MACP siTNF-α NPs被M1巨细胞优先内化,并避免了溶酶体降解.
- 该系统有效地减少了活性氧物种 (ROS),并防止了谷氨 (GSH) 的耗尽.
- 一个积极的反循环增强了瘤亡因子-α (TNF-α) 和ROS清理的基因沉默.
结论:
- 在RA中,MACP siTNF-α NPs提供了针对炎症和氧化应激的双重治疗机制.
- 生物模拟纳米平台显示了在RA治疗中有效逆转巨细胞表型的潜力.
更多相关视频
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
8.6K
09:18Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
7.1K
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
